Xiangyu Chen

Years Active: 2020-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Xiangyang Wang, Xiangyu Chen, Jierong Chen, Chunhui Liao, Xiaofan Yang, Jiasheng Zhou, Shanshan Liu, Shusen Ye, Yuhao Zheng, Linzi Huang, Jiacong Zhao, Lilin Ye, Bihui Huang, Yingjiao Cao
Dopamine Receptor 1 Impedes ILC2-Mediated Antitumor Immunity. Journal of immunology (Baltimore, Md. : 1950) (2023)
Mengqi Yuan, Xiangyu Chen, Yanzhi Zhu, Xiaoqing Dong, Yan Liu, Zhaohui Qian, Lilin Ye, Pinghuang Liu
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern. Journal of virology 96 (16) (2022)
Ren Li, Zhiwei Pan, Jialin Wu, Shuai Yue, Yao Lin, Yang Yang, Zhirong Li, Li Hu, Jianfang Tang, Lingling Shan, Qin Tian, Peng Jiang, Ping Wei, Lilin Ye, Pinghuang Liu, Xiangyu Chen
The Epigenetic Regulator EZH2 Instructs CD4 T Cell Response to Acute Viral Infection via Coupling of Cell Expansion and Metabolic Fitness. Journal of virology 94 (24) (2020)

Xiangyu Chen.css-eqlu8i{font-size:small;padding-left:4px;}